S

Shenzhen FRD Science & Technology Co Ltd
SZSE:300602

Watchlist Manager
Shenzhen FRD Science & Technology Co Ltd
SZSE:300602
Watchlist
Price: 20.91 CNY 5.98% Market Closed
Market Cap: 12.1B CNY
Have any thoughts about
Shenzhen FRD Science & Technology Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Shenzhen FRD Science & Technology Co Ltd

Current Assets 4.3B
Cash & Short-Term Investments 1.2B
Receivables 2.1B
Other Current Assets 1.1B
Non-Current Assets 3.1B
Long-Term Investments 74.7m
PP&E 2.2B
Intangibles 442.5m
Other Non-Current Assets 403.4m
Current Liabilities 2.8B
Accounts Payable 1.2B
Accrued Liabilities 87.2m
Short-Term Debt 1.1B
Other Current Liabilities 469.5m
Non-Current Liabilities 860m
Long-Term Debt 430.3m
Other Non-Current Liabilities 429.7m

Balance Sheet
Shenzhen FRD Science & Technology Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
102
144
192
590
429
237
927
643
556
1 212
Cash
0
26
0
0
0
1
0
643
556
1 212
Cash Equivalents
102
118
192
590
429
236
927
0
0
0
Short-Term Investments
0
0
0
0
0
35
0
6
0
0
Total Receivables
251
286
371
461
658
1 392
1 093
1 482
1 794
2 151
Accounts Receivables
219
248
341
403
542
1 166
851
1 211
1 510
1 754
Other Receivables
32
38
30
59
116
226
242
270
283
397
Inventory
51
63
117
133
200
492
545
811
836
809
Other Current Assets
1
2
6
10
8
54
106
76
69
58
Total Current Assets
405
495
685
1 194
1 295
2 210
2 671
3 017
3 256
4 230
PP&E Net
84
144
181
213
385
825
1 284
1 653
2 069
2 171
PP&E Gross
0
144
181
213
385
825
1 284
1 653
2 069
2 171
Accumulated Depreciation
0
47
58
72
85
276
356
488
623
758
Intangible Assets
19
18
18
18
117
199
289
328
330
342
Goodwill
0
1
1
1
1
161
138
104
104
101
Long-Term Investments
2
1
0
4
4
0
25
60
109
117
Other Long-Term Assets
6
9
13
22
71
249
282
367
417
422
Other Assets
0
1
1
1
1
161
138
104
104
101
Total Assets
515
N/A
669
+30%
898
+34%
1 451
+62%
1 873
+29%
3 644
+95%
4 689
+29%
5 529
+18%
6 285
+14%
7 383
+17%
Liabilities
Accounts Payable
117
142
234
202
351
795
764
1 024
1 147
1 293
Accrued Liabilities
8
11
18
22
39
83
69
78
90
119
Short-Term Debt
22
26
29
29
43
527
735
1 202
1 445
905
Current Portion of Long-Term Debt
0
0
12
0
0
14
0
58
142
388
Other Current Liabilities
12
14
8
8
68
92
46
47
43
54
Total Current Liabilities
158
193
300
260
500
1 512
1 613
2 409
2 867
2 759
Long-Term Debt
0
12
11
0
0
0
76
166
427
473
Deferred Income Tax
0
0
0
0
0
36
41
54
88
83
Minority Interest
0
6
10
8
12
266
261
183
98
79
Other Liabilities
8
14
23
222
214
301
271
266
251
260
Total Liabilities
166
N/A
224
+35%
343
+53%
491
+43%
726
+48%
2 115
+191%
2 263
+7%
3 078
+36%
3 732
+21%
3 653
-2%
Equity
Common Stock
75
75
75
100
204
306
507
508
508
578
Retained Earnings
217
312
422
520
672
1 010
1 189
1 193
1 284
1 427
Additional Paid In Capital
58
58
58
341
324
244
742
734
745
1 717
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
19
Treasury Stock
0
0
0
0
53
31
15
17
17
10
Other Equity
0
0
0
0
0
0
4
33
33
0
Total Equity
349
N/A
445
+27%
555
+25%
960
+73%
1 148
+19%
1 529
+33%
2 426
+59%
2 451
+1%
2 553
+4%
3 729
+46%
Total Liabilities & Equity
515
N/A
669
+30%
898
+34%
1 451
+62%
1 873
+29%
3 644
+95%
4 689
+29%
5 529
+18%
6 285
+14%
7 383
+17%
Shares Outstanding
Common Shares Outstanding
353
353
353
471
481
481
507
505
506
577

See Also

Discover More